JPH0539485A - Liquid crystal composition and cosmetic containing the same - Google Patents
Liquid crystal composition and cosmetic containing the sameInfo
- Publication number
- JPH0539485A JPH0539485A JP3194316A JP19431691A JPH0539485A JP H0539485 A JPH0539485 A JP H0539485A JP 3194316 A JP3194316 A JP 3194316A JP 19431691 A JP19431691 A JP 19431691A JP H0539485 A JPH0539485 A JP H0539485A
- Authority
- JP
- Japan
- Prior art keywords
- liquid crystal
- crystal composition
- weight
- acid
- polysaccharide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
Description
【０００１】[0001]
【産業上の利用分野】本発明は、強くて色幅の広い発色
性を有し、透明感、鮮やかさ等の審美感が良好で、かつ
経時的に安定である新規な液晶組成物及びこれを含有
し、優れた使用感を有する化粧料に関する。FIELD OF THE INVENTION The present invention relates to a novel liquid crystal composition having strong and wide color-developing properties, good aesthetics such as transparency and vividness, and stable over time. The present invention relates to a cosmetic composition which contains the following:
【０００２】[0002]
【従来の技術】従来、液晶組成物は種々の界面活性剤及
びステロール類等を原料として調製されている。また、
これらの中でも特に優れた発色性を有するものは、神秘
的な外観を有することから様々な装飾品や化粧品などへ
の使用が試みられている。2. Description of the Related Art Conventionally, liquid crystal compositions have been prepared by using various surfactants and sterols as raw materials. Also,
Among them, those having particularly excellent color developability have been attempted to be used in various ornaments and cosmetics because they have a mysterious appearance.
【０００３】[0003]
【発明が解決しようとする課題】しかしながら、従来の
液晶組成物は、その発色が弱いばかりでなく、その色幅
も狭く、透明感・鮮やかさも不十分であり、また経時安
定性の面でも充分満足し得るものではなかった。However, the conventional liquid crystal compositions are not only weak in color development, but also have a narrow color width, insufficient transparency and vividness, and are sufficient in terms of stability over time. It wasn't satisfactory.
【０００４】[0004]
【課題を解決するための手段】斯かる実情において、本
発明者らは鋭意研究を行った結果、リン脂質、糖脂質又
はスフィンゴ脂質、ステロール類及び特定の補助成分を
配合すれば、極めて発色性に富み、審美感に優れ、かつ
経時的にも安定な液晶組成物が得られること、またこれ
を配合すれば当該液晶組成物の特徴を具有し、優れた使
用感を有する化粧料が得られることを見出し本発明を完
成した。Under the circumstances, as a result of intensive studies, the present inventors have found that if a phospholipid, a glycolipid or a sphingolipid, a sterol and a specific auxiliary component are blended, the coloring property becomes extremely high. A liquid crystal composition that is rich in aesthetics and is stable over time is obtained, and when it is blended, a cosmetic having the characteristics of the liquid crystal composition and an excellent usability is obtained. It was found that the present invention has been completed.
【０００５】すなわち、本発明は、次の成分（ａ）、
（ｂ）及び（ｃ）、（ａ）リン脂質、糖脂質又はスフィ
ンゴ脂質の一種又は二種以上０．０１〜４重量％、
（ｂ）ステロール類０．０１〜２重量％、（ｃ）高分子
電解質０．０００１〜０．０５重量％、多糖類生薬抽出
物０．０００１〜０．０５重量％又は低分子化合物０．
０００１〜１０重量％の一種又は二種以上、を含有する
液晶組成物、並びにこれを含有する化粧料を提供するも
のである。That is, the present invention provides the following component (a),
0.01 to 4% by weight of (b) and (c), (a) one or more of phospholipids, glycolipids or sphingolipids,
(B) Sterols 0.01 to 2% by weight, (c) Polyelectrolyte 0.0001 to 0.05% by weight, Polysaccharide crude drug extract 0.0001 to 0.05% by weight or low molecular compound 0.
The present invention provides a liquid crystal composition containing 0001 to 10% by weight of one or more kinds, and a cosmetic containing the same.
【０００６】本発明に用いられる（ａ）成分のリン脂質
としては、ホスファチジルコリン、ホスファチジルエタ
ノールアミン等のグリセロリン脂質、スフィンゴミエリ
ン等のスフィンゴリン脂質等が挙げられ、これは大豆や
卵黄等由来の天然のものやこれを精製、水添等したもの
でも、また合成したのものでも良い。糖脂質としては、
セレブロシド、ガングリオシド等のスフィンゴ糖脂質、
ジガラクトシルジグリセリド等の糖脂質等が挙げられ、
これは牛脳等由来の天然のものやこれを精製等したもの
でも、また合成のものでも良い。スフィンゴ脂質として
は、上記スフィンゴリン脂質、スフィンゴ糖脂質として
挙げられるものの他、セラミド等が挙げられる。Examples of the phospholipids as the component (a) used in the present invention include glycerophospholipids such as phosphatidylcholine and phosphatidylethanolamine, and sphingolinphospholipids such as sphingomyelin, which are naturally derived from soybeans and egg yolks. The product may be purified, hydrogenated, or synthesized. As a glycolipid,
Glycosphingolipids such as cerebroside and ganglioside,
And glycolipids such as digalactosyl diglyceride,
This may be a natural product derived from bovine brain or the like, a purified product thereof, or a synthetic product. Examples of the sphingolipid include ceramide and the like in addition to the above-mentioned sphingolipids and glycosphingolipids.
【０００７】また（ｂ）成分のステロール類としては、
例えばコレステロール、コレスタノール、ラノステロー
ル、セレグロステロール、デヒドロコレステロール、コ
プロスタノール等の動物性ステロール類；β−シトステ
ロール、スチグマステロール、カンペステロール、エル
ゴステロール等の植物性ステロール類；ミコステロー
ル、チモステロール等の微生物由来ステロール類などが
挙げられ、特にコレステロール、コレスタノールが好ま
しい。これらのステロール類は一種又は二種以上を組み
合わせて配合することができる。Further, as the sterols as the component (b),
For example, animal sterols such as cholesterol, cholestanol, lanosterol, selegrosterol, dehydrocholesterol, coprostanol; plant sterols such as β-sitosterol, stigmasterol, campesterol, ergosterol; mycosterol, timosterol, etc. The microorganism-derived sterols are listed, and cholesterol and cholestanol are particularly preferable. These sterols can be blended alone or in combination of two or more.
【０００８】本発明において、（ｃ）成分は、本発明液
晶組成物の発色を向上させ、その濃度を調節することに
よってその色調をコントロールし、液晶組成物を安定化
させる目的で配合される。In the present invention, the component (c) is added for the purpose of improving the color development of the liquid crystal composition of the present invention, controlling the color tone by adjusting the concentration thereof, and stabilizing the liquid crystal composition.
【０００９】（ｃ）成分の高分子電解質としては、ヒア
ルロン酸ナトリウム等のムコ多糖類；ＤＮＡ−ナトリウ
ム等の核酸類；ヒアルロン酸−タンパク複合体等の糖タ
ンパク類；加水分解コラーゲン、加水分解ケラチン等の
ペプチド類；水溶性コラーゲン等の水溶性蛋白質；ガラ
クトマンナン、アラビアガム等の植物系高分子電解質；
カラギーナン等の海草系高分子電解質；キサンタンガム
等の微生物系高分子電解質；ポリアクリル酸ナトリウム
等の合成高分子電解質等が挙げられる。これらの高分子
電解質は一種又は二種以上を組み合せて配合することが
できる。Examples of the polyelectrolyte as the component (c) include mucopolysaccharides such as sodium hyaluronate; nucleic acids such as DNA-sodium; glycoproteins such as hyaluronic acid-protein complex; hydrolyzed collagen and hydrolyzed keratin. Peptides such as; water-soluble proteins such as water-soluble collagen; plant-based polyelectrolytes such as galactomannan and gum arabic;
Seagrass-based polymer electrolytes such as carrageenan; microbial-based polymer electrolytes such as xanthan gum; synthetic polymer electrolytes such as sodium polyacrylate. These polymer electrolytes can be blended alone or in combination of two or more.
【００１０】（ｃ）成分の多糖類生薬とは、多糖類を含
有する薬理効果を有する植物を指称し、具体的には、ハ
マメリス（アンチク科）、サルビア、バーチ（シソ
科）、ソウハクヒ、ホップ（クワ科）、マルメロ、シモ
ッケ（バラ科）、アロエベラ、百合球根、アローケープ
（ユリ科）、人参（ウコキ科）、アマ（アマ科）、カミ
ツレ、フキタンポポ、カモミル（キク科）、コロリ（マ
メ科）、プシリウム（オオバコ科）、ゼニアオイ、アム
テイア、ビロウドアオイ（アオイ科）、西洋菩提樹、菩
提樹（シナノキ科）、オトギリソウ（オトギリソウ
科）、ニワトコ（スイカズラ科）、ヒナゲシ（ケシ
科）、オウバク（ミカン科）、マロニエ（トチノキ
科）、キューカンバ（ウリ科）、ウィッチヘーゼル（マ
ンサク科）、ローズマリー（シソ科）、タイソウ（クロ
ウメモドキ科）、カイソウ（ヒバマタ科）、ヤハズツノ
マタ（スギ科）等が挙げられる。The component (c), a polysaccharide crude drug, refers to a plant containing a polysaccharide and having a pharmacological effect, and specifically, Hamamelis (Antiaceae), Salvia, Birch (Lamiaceae), Sophoraceae, Hop (Mulaceae), quince, simoke (Rosaceae), aloe vera, lily bulb, arrow cape (Liliaceae), carrot (Uricaceae), flax (Lamiaceae), chamomile, dandelion, chamomile (Asteraceae), korori (legume) Family), Psyllium (Plantaceae), Mallow, Amtia, Birodoaoi (Mallowaceae), Western linden tree, Bodhi tree (lindenaceae), Hypericum (Hypericaceae), Sambucus (Loniceraeaceae), Poppy (Amsteraceae), Otteraceae Family), horse chestnut (Hinaceae), cucumber (Cucurbitaceae), witch hazel (Hawthorne), rosemary (Lamiaceae) , Gymnastics (rhamnaceae), seaweed (Fucus family), Yahazutsunomata (cedar family), and the like.
【００１１】多糖類生薬の抽出物は、上記の多糖類生薬
の葉、花、枝、果実などから抽出して得られるものであ
る。抽出方法は特に限定されず、例えば、抽出溶媒とし
て水、メチルアルコール、エチルアルコール等の１級ア
ルコール、プロピレングリコール、１，３−ブチレング
リコール等の液状多価アルコール、酢酸エチルエステル
等の低級アルキルエステル、ベンゼン、ヘキサン等の炭
化水素、エチルエーテル、アセトン等の公知の溶媒を用
いる方法が採用され、これら溶媒は一種又は二種以上を
組み合せて使用することができる。就中、好ましい抽出
溶媒としては、水と混和する有機溶媒の水溶液、特に、
エチルアルコール、メチルアルコール、アセトン等の水
溶液が挙げられる。抽出物としては、多糖類生薬を上記
抽出溶媒に浸漬し、これを室温で、又は加温下抽出し、
濾過して得られた抽出液をそのまま用いても良いが、更
に必要により濃縮したものを用いても良い。また、これ
らの抽出物を精製して用いることもできる。The polysaccharide crude drug extract is obtained by extracting from the leaves, flowers, branches, fruits, etc. of the above-mentioned polysaccharide crude drugs. The extraction method is not particularly limited, and examples thereof include water, primary alcohols such as methyl alcohol and ethyl alcohol, liquid polyhydric alcohols such as propylene glycol and 1,3-butylene glycol, and lower alkyl esters such as ethyl acetate. A method of using a known solvent such as hydrocarbons such as benzene and hexane, ethyl ether, acetone and the like is adopted, and these solvents can be used alone or in combination of two or more kinds. Among them, the preferred extraction solvent is an aqueous solution of an organic solvent miscible with water, particularly,
Examples thereof include aqueous solutions of ethyl alcohol, methyl alcohol, acetone and the like. As the extract, the polysaccharide crude drug is immersed in the extraction solvent, and this is extracted at room temperature or under heating,
The extract obtained by filtration may be used as it is, or may be further concentrated if necessary. Also, these extracts can be purified and used.
【００１２】更に、（ｃ）成分の低分子化合物として
は、ＮａＣｌ、ＫＣｌ、ＣａＣｌ2、ＭｇＳＯ4、ＮａＨ
2ＰＯ4・Ｈ2Ｏ等のアルカリ又はアルカリ土類金属の
塩；アラニン、グリシン等のアミノ酸；ピロリドンカル
ボン酸、乳酸、クエン酸、リンゴ酸、酒石酸等の有機酸
及びその塩；グルコース、フルクトース、キシロース、
サッカロース、マンニット、Ｎ−アセチルグルコサミ
ン、Ｎ−アセチルノイラミン酸（シアル酸）、コロミン
酸、キチンオリゴマー等の単糖類又はオリゴマー及びそ
の塩等が挙げられる。Further, as the low molecular weight compound of the component (c), NaCl, KCl, CaCl 2 , MgSO 4 , NaH
Alkaline or alkaline earth metal salts such as 2 PO 4 .H 2 O; amino acids such as alanine and glycine; organic acids such as pyrrolidonecarboxylic acid, lactic acid, citric acid, malic acid, tartaric acid and salts thereof; glucose, fructose, Xylose,
Examples include monosaccharides or oligomers such as saccharose, mannitol, N-acetylglucosamine, N-acetylneuraminic acid (sialic acid), colominic acid, chitin oligomers and salts thereof.
【００１３】本発明の液晶組成物には、上記（ａ）、
（ｂ）及び（ｃ）成分のほかに、更に（ｄ）高級脂肪
酸、（ｅ）ローカストビーンガム及び／又はグアーガム
を添加することができる。The liquid crystal composition of the present invention comprises the above (a),
In addition to the components (b) and (c), (d) higher fatty acid, (e) locust bean gum and / or guar gum can be added.
【００１４】（ｄ）成分は液晶組成物の生成を容易に
し、またその種類や濃度を調節するこにより、流動性や
温度安定性をコントロールする作用を有する。高級脂肪
酸としては、炭素数１２〜２２、特に１４〜１８の直鎖
又は側鎖を有する飽和又は不飽和の脂肪酸、例えばパル
ミチン酸、オレイン酸、リノール酸、γ−リノレン酸、
アラキドン酸等が挙げられる。The component (d) has the function of facilitating the production of the liquid crystal composition and controlling the fluidity and temperature stability by adjusting the type and concentration thereof. As the higher fatty acid, a saturated or unsaturated fatty acid having a straight chain or a side chain having 12 to 22 carbon atoms, particularly 14 to 18, such as palmitic acid, oleic acid, linoleic acid, γ-linolenic acid,
Examples include arachidonic acid.
【００１５】（ｅ）成分は液晶組成物の経時安定性を向
上させると共に、使用感の幅を広げる作用を有する。ロ
ーカストビーンガム及びグアーガムはその純度に制限は
なく、市販品を用いることができる。The component (e) has the functions of improving the stability of the liquid crystal composition over time and broadening the range of usability. The purity of locust bean gum and guar gum is not limited, and commercially available products can be used.
【００１６】本発明の液晶組成物において、上述の各成
分は、本発明組成物中に、（ａ）は０．０１〜４重量％
（以下単に％で示す）、（ｂ）は０．０１〜２％、
（ｃ）は高分子電解質及び多糖類生薬抽出物（固形分換
算で）の場合は０．０００１〜０．０５％、低分子化合
物の場合は０．０００１〜１０％、（ｄ）は０．０１〜
２．０％、（ｅ）は０．０００１〜０．０５％になるよ
うに配合される。In the liquid crystal composition of the present invention, each of the above components is 0.01 to 4% by weight in the composition of the present invention.
(Hereinafter referred to simply as%), (b) is 0.01 to 2%,
(C) is 0.0001 to 0.05% in the case of a polyelectrolyte and a polysaccharide crude drug extract (in terms of solid content), 0.0001 to 10% in the case of a low molecular weight compound, and (d) is 0. 01 ~
2.0% and (e) are compounded so as to be 0.0001 to 0.05%.
【００１７】（ａ）成分がこれ未満であると本発明の液
晶組成物が得られず、これを超えると系が乳化してしま
い好ましくなく、（ｂ）成分がこれ未満であると本発明
の液晶組成物が得られず、これを超えるとステロール類
の結晶が析出してしまい好ましくない。（ｃ）成分がこ
れ未満であると本発明の液晶組成物が膨潤白化してしま
い、これを超えると逆に液晶組成物の発色が阻害され好
ましくない。また、（ｄ）成分がこれを超えると本発明
の液晶組成物が得られず、（ｅ）成分がこれを超えると
液晶組成物の発色が阻害され好ましくない。When the component (a) is less than this, the liquid crystal composition of the present invention cannot be obtained, and when it exceeds this, the system is emulsified, which is not preferable, and when the component (b) is less than this, the liquid crystal composition of the present invention is not obtained. A liquid crystal composition cannot be obtained, and if it exceeds this range, crystals of sterols are precipitated, which is not preferable. If the amount of component (c) is less than this, the liquid crystal composition of the present invention swells and whitens, and if it exceeds this, the color development of the liquid crystal composition is adversely affected, which is not preferable. Further, when the component (d) exceeds this amount, the liquid crystal composition of the present invention cannot be obtained, and when the component (e) exceeds this, the color development of the liquid crystal composition is inhibited, which is not preferable.
【００１８】本発明の液晶組成物は、例えば（ｃ）、
（ｄ）及び（ｅ）成分を加えた精製水に（ａ）成分、
（ｂ）成分の加熱溶解物を添加し、必要に応じて混合撹
拌する方法により得ることができるが、（ｃ）〜（ｅ）
成分を加えた精製水と、（ａ）成分、（ｂ）成分を粉末
状としたものを使用時に混合するようにしてもよい。精
製水に添加される（ａ）〜（ｅ）成分の量は、液晶組成
物全体に対し、全量で０．００５〜５％、特に０．１〜
３．５％が好ましい。かかる添加成分（ａ）〜（ｅ）の
合計が５％を超えると液晶組成物が充分に膨潤せず発色
性が低下し、逆に０．００５％未満でも液晶組成物が希
薄になるため発色性が低下し、好ましくない。The liquid crystal composition of the present invention comprises, for example, (c),
Component (a) in purified water containing components (d) and (e),
It can be obtained by a method of adding a heat-dissolved product of the component (b) and, if necessary, mixing and stirring, and (c) to (e).
Purified water containing the components may be mixed with powders of the components (a) and (b) at the time of use. The total amount of components (a) to (e) added to the purified water is 0.005 to 5%, particularly 0.1 to 5% with respect to the entire liquid crystal composition.
3.5% is preferable. When the total amount of the additive components (a) to (e) exceeds 5%, the liquid crystal composition does not swell sufficiently and the color developability deteriorates. On the contrary, when it is less than 0.005%, the liquid crystal composition becomes dilute, resulting in color formation. This is not preferable because it deteriorates the property.
【００１９】本発明の液晶組成物はそのままであるい
は、一般に化粧料に使用される化粧料成分を本発明の効
果を損わない範囲で適宜配合することにより、化粧水、
クリーム、美容液等の化粧料として用いることができ
る。ここで、化粧料成分としては、トリグリセリド、炭
化水素油、エステル油、ワックス又は高級アルコール等
の油成分、着色顔料、体質顔料又はパール光沢付与剤等
の粉体成分、pH調整剤、防腐剤、酸化防止剤、キレート
剤、保湿剤、美容成分、香料などが挙げられる。To the skin lotion, the liquid crystal composition of the present invention can be used as it is, or by appropriately mixing cosmetic ingredients generally used in cosmetics within a range that does not impair the effects of the present invention.
It can be used as a cosmetic such as cream or beauty essence. Here, as the cosmetic ingredients, triglycerides, hydrocarbon oils, ester oils, oil components such as wax or higher alcohols, color components, powder components such as extender pigments or pearl luster imparting agents, pH adjusters, preservatives, Antioxidants, chelating agents, moisturizers, beauty ingredients, perfumes and the like can be mentioned.
【００２０】[0020]
【実施例】次に実施例を挙げて本発明を説明する。EXAMPLES Next, the present invention will be described with reference to examples.
【００２１】実施例１〜１２ 表１に示す組成のマーブル状液晶分散液を調製し、色
調、透明度、鮮明度を目視により評価した。 （製法） Ａ．（１）〜（４）を加熱溶解する。 Ｂ．（５）〜（１１）を均一溶解する。 Ｃ．ＢにＡを０．０２mlずつ滴下する。 滴下後、１日放置して、直径が１０mm程度のマーブル状
液晶が数十個分散した美しいマーブル状液晶分散液を得
た。 （評価基準） 色調 透明なガラスびんに入れた試料の背後に黒色の紙を置い
て観察した。 マーブルの透明度 ○：良好 △：ややおとる ×：濁りがみられる マーブルの鮮明度 ○：良好 △：ややおとる ×：おとる （結果）得られた結果を表１に示すExamples 1 to 12 Marble liquid crystal dispersions having the compositions shown in Table 1 were prepared, and the color tone, transparency and clarity were visually evaluated. (Production method) A. (1) to (4) are heated and dissolved. B. (5) to (11) are uniformly dissolved. C. 0.02 ml of A is added dropwise to B. After dropping, the mixture was left for 1 day to obtain a beautiful marble-like liquid crystal dispersion liquid in which several tens of marble-like liquid crystals having a diameter of about 10 mm were dispersed. (Evaluation Criteria) Color Tone: Black paper was placed behind a sample placed in a transparent glass bottle and observed. Transparency of marble ○: Good Δ: Somewhat poor ×: Turbidity is seen Marble clarity ○: Good Δ: Somewhat poor ×: Very good (result) The obtained results are shown in Table 1.
【００２２】[0022]
【表１】 [Table 1]
【００２３】表１の結果から明らかな如く、実施例１〜
１２のマーブル状液晶分散液は、透明度、鮮明度共に優
れ、外観美麗なものであった。As is clear from the results shown in Table 1, Examples 1 to 1
The marbled liquid crystal dispersion liquid of No. 12 was excellent in both transparency and sharpness and had a beautiful appearance.
【００２４】実施例１３〜２６ 表２に示す組成の液晶ローションを調製し、その色調、
透明度、鮮明度を目視により評価した。 （製法） Ａ．（１）〜（３）を加熱溶解する。 Ｂ．（４）〜（１３）を均一に溶解する。 Ｃ．ＢにＡを添加し、均一に混合撹拌する。 （評価基準）実施例１〜１２と同じ。 （結果）得られた結果を表２に示す。Examples 13 to 26 Liquid crystal lotions having the compositions shown in Table 2 were prepared and their color tones were evaluated.
The transparency and sharpness were visually evaluated. (Production method) A. (1) to (3) are heated and dissolved. B. (4) to (13) are uniformly dissolved. C. Add A to B and mix and stir uniformly. (Evaluation criteria) Same as Examples 1 to 12. (Results) The obtained results are shown in Table 2.
【００２５】[0025]
【表２】 [Table 2]
【００２６】表２の結果から明らかな如く、実施例１３
〜２６の液晶ローションは、透明度、鮮明度共に優れ、
外観の良いものであった。As is clear from the results of Table 2, Example 13
Liquid crystal lotions of ~ 26 have excellent transparency and sharpness,
The appearance was good.
【００２７】実施例２７ 帯状液晶分散液 （組成） （重量％） （１）水添大豆レシチン 0.05 （２）セレブロシド 0.25 （３）コレステロール 0.14 （４）オレイン酸 0.1 （５）パルミチン酸 0.1 （６）マカデミアンナッツ油 0.25 （７）コレステリルオレエート 0.05 （８）グアーガム 0.005 （９）アロエベラ 0.003 （10）１，３−ブチレングリコール 1.8 （11）防腐剤 0.2 （12）香料 0.01 （13）精製水 残量 （製法） Ａ．（１）〜（７）を加熱溶解し、１０〜５０mmの長方
形の型に流し込み、冷却し、０．２〜０．３mm程度の厚
みの板状体を調製する。 Ｂ．（８）〜（１３）を均一に溶解する。 Ｃ．ＢにＡを加える。 得られた帯状液晶分散液は、溶液の中に幅が３０mm程度
の黄緑色の帯状体が横たわる美しい外観を有し、透明
度、鮮明度も良好で、しっとりした感触で使用感も非常
に優れ、経時的にも安定なものであった。Example 27 Strip liquid crystal dispersion (composition) (% by weight) (1) hydrogenated soybean lecithin 0.05 (2) cerebroside 0.25 (3) cholesterol 0.14 (4) oleic acid 0.1 (5) palmitic acid 0.1 (6) Macadamian nut oil 0.25 (7) Cholesteryl oleate 0.05 (8) Guar gum 0.005 (9) Aloe vera 0.003 (10) 1,3-butylene glycol 1.8 (11) Preservative 0.2 (12) Perfume 0.01 (13) Purified water Remaining amount (Production method) A. (1) to (7) are melted by heating, poured into a rectangular mold of 10 to 50 mm, and cooled to prepare a plate-shaped body having a thickness of about 0.2 to 0.3 mm. B. (8) to (13) are uniformly dissolved. C. Add A to B. The obtained band-shaped liquid crystal dispersion has a beautiful appearance in which a yellow-green band having a width of about 30 mm lies in the solution, has good transparency and sharpness, and has a moist feel and an excellent feeling in use. It was stable over time.
【００２８】実施例２８ 液晶ローション （組成） （重量％） （１）水添大豆レシチン 0.25 （２）スフィンゴミエリン 0.02 （３）コレステロール 0.13 （４）ムチン 0.001 （５）ガングリオシド 0.001 （６）ヒアルロン酸ナトリウム 0.004 （７）グリシン 0.1 （８）塩化ナトリウム 0.001 （９）１，３−ブチレングリコール 2.8 （10）防腐剤 0.2 （11）香料 0.01 （12）精製水 残量 （製法） Ａ．（１）〜（３）に（９）の一部を加え加熱溶解す
る。 Ｂ．（４）〜（８）、（９）の残量、（１０）〜（１
２）を均一に溶解する。 Ｃ．ＢにＡを加え、均一に混合撹拌する。 得られた液晶ローションは、透明度がみられる色鮮やか
な紫色を呈する美しい外観を有し、さっぱりした感触で
使用感も優れ、経時的にも安定なものであった。Example 28 Liquid Crystal Lotion (Composition) (wt%) (1) Hydrogenated soybean lecithin 0.25 (2) Sphingomyelin 0.02 (3) Cholesterol 0.13 (4) Mucin 0.001 (5) Ganglioside 0.001 (6) Sodium hyaluronate 0.004 (7) Glycine 0.1 (8) Sodium chloride 0.001 (9) 1,3-butylene glycol 2.8 (10) Preservative 0.2 (11) Perfume 0.01 (12) Purified water Residual amount (Production method) A. A part of (9) is added to (1) to (3) and dissolved by heating. B. (4) to (8), the remaining amount of (9), (10) to (1
Dissolve 2) uniformly. C. Add A to B and mix and stir uniformly. The obtained liquid crystal lotion had a beautiful appearance with a vivid purple color with transparency, a refreshing feel, an excellent feeling in use, and was stable over time.
【００２９】実施例２９ マーブル状液晶分散液 （組成） （重量％） （１）水添大豆レシチン 0.41 （２）セレブロシド 0.28 （３）コレステロール 0.22 （４）ローカストビーンガム 0.01 （５）キサンタンガム 0.01 （６）グリセリン 5.0 （７）１，３−ブチレングリコール 5.0 （８）防腐剤 0.1 （９）香料 0.01 （10）精製水 残量 （製法） Ａ．（１）〜（３）に（７）の一部を加え、加熱溶解す
る。 Ｂ．（４）〜（６）、（７）の残量、（８）〜（１０）
を均一に溶解する。 Ｃ．ＢにＡを滴下する。 得られたマーブル状液晶分散液は、溶液の中に直径が１
０mm程度の紫色のマーブル状液晶が分散した美しい外観
を有し、さっぱりした良好な使用感を有し、経時的にも
安定なものであった。Example 29 Marbled Liquid Crystal Dispersion (Composition) (wt%) (1) Hydrogenated soybean lecithin 0.41 (2) Cerebroside 0.28 (3) Cholesterol 0.22 (4) Locust bean gum 0.01 (5) Xanthan gum 0.01 (6) ) Glycerin 5.0 (7) 1,3-butylene glycol 5.0 (8) Preservative 0.1 (9) Perfume 0.01 (10) Purified water Remaining amount (production method) A. A part of (7) is added to (1) to (3) and heated to dissolve. B. (4) to (6), the remaining amount of (7), (8) to (10)
Dissolve evenly. C. A is added dropwise to B. The resulting marble-like liquid crystal dispersion has a diameter of 1 in the solution.
It had a beautiful appearance in which a purple marble-like liquid crystal of about 0 mm was dispersed, had a refreshing good feeling of use, and was stable over time.
【００３０】[0030]
【発明の効果】本発明の液晶組成物及びこれを含有する
化粧料は、強くて色幅の広い発色性を有し、透明感、鮮
やかさ等の審美感が良好で、かつ経時的安定性もよいと
共に、使用感も優れている。EFFECT OF THE INVENTION The liquid crystal composition of the present invention and the cosmetics containing the same have strong and wide color-developing color developability, good aesthetics such as transparency and vividness, and stability over time. Not only good, but also excellent in usability.
Claims (4)
二種以上０．０１〜４重量％、 （ｂ）ステロール類０．０１〜２重量％、 （ｃ）高分子電解質０．０００１〜０．０５重量％、多
糖類生薬抽出物０．０００１〜０．０５重量％又は低分
子化合物０．０００１〜１０重量％の一種又は二種以
上、 を含有する液晶組成物。1. The following components (a), (b) and (c), (a) 0.01 to 4% by weight of one or more of phospholipids, glycolipids or sphingolipids, and (b) sterols. 0.01 to 2% by weight, (c) polymer electrolyte 0.0001 to 0.05% by weight, polysaccharide crude drug extract 0.0001 to 0.05% by weight or low molecular weight compound 0.0001 to 10% by weight A liquid crystal composition containing one kind or two or more kinds.
（ｃ）にさらに（ｄ）高級脂肪酸０．０１〜２重量％を
含有する液晶組成物。2. A liquid crystal composition comprising the components (a), (b) and (c) according to claim 1 and further comprising (d) 0.01 to 2% by weight of a higher fatty acid.
（ｃ）にさらに（ｅ）ローカストビーンガム及び／又は
グアーガム０．０００１〜０．０５重量％を含有する液
晶組成物。3. A liquid crystal composition containing the components (a), (b) and (c) of claim 1 and (e) 0.0001 to 0.05% by weight of locust bean gum and / or guar gum.
組成物を含有する化粧料。4. A cosmetic containing the liquid crystal composition according to claim 1.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3194316A JPH0539485A (en) | 1991-08-02 | 1991-08-02 | Liquid crystal composition and cosmetic containing the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3194316A JPH0539485A (en) | 1991-08-02 | 1991-08-02 | Liquid crystal composition and cosmetic containing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH0539485A true JPH0539485A (en) | 1993-02-19 |
Family
ID=16322577
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP3194316A Pending JPH0539485A (en) | 1991-08-02 | 1991-08-02 | Liquid crystal composition and cosmetic containing the same |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0539485A (en) |
Cited By (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995019762A1 (en) * | 1994-01-19 | 1995-07-27 | Taisho Pharmaceutical Co., Ltd. | Dermatologic composition |
| FR2730409A1 (en) * | 1995-02-15 | 1996-08-14 | Dior Christian Parfums | USE OF GALACTOLIPIDS, IN PARTICULAR GALACTOSYLGLYCERIDES, AND EXTRACTS OF NATURAL ORIGIN CONTAINING THESE PRODUCTS, IN THE COSMETIC, PHARMACEUTICAL AND IN PARTICULAR DERMATOLOGICAL FIELDS |
| EP0875232A1 (en) * | 1997-05-02 | 1998-11-04 | Takasago International Corporation | A lipid composition containing liquid crystal phase |
| WO1998056338A1 (en) * | 1997-06-10 | 1998-12-17 | Sunstar Inc. | Skin-lightening cosmetic |
| EP1043016A1 (en) * | 1999-03-30 | 2000-10-11 | Sodic Sa | A plant extract based on glycerides, a method for the preparation of this extract and a cosmetic composition containing the same |
| US6306915B1 (en) | 1998-08-07 | 2001-10-23 | Kibun Food Chemifa Co., Ltd | Methods of making an emulsified composition |
| US6348201B2 (en) | 1997-05-30 | 2002-02-19 | Kibun Food Chemifa Co., Ltd. | External composition for skin comprising sphingoglycolipid |
| US6723704B2 (en) | 2000-06-29 | 2004-04-20 | Kibun Food Chemifa Co., Ltd. | Sphingoglycolipid |
| KR100434898B1 (en) * | 2001-06-26 | 2004-06-07 | 나드리화장품주식회사 | Cosmetic composition containing medical plant complex extracts stabilized with liquid crystalsome |
| KR100439595B1 (en) * | 2001-05-18 | 2004-07-12 | 주식회사 엘지생활건강 | Tocopherol-containing Ceramide Liquid Crystal Capsule, Emulsion thereof and Cosmetic comprising the same |
| KR100567373B1 (en) * | 1998-12-17 | 2007-03-15 | 주식회사 엘지생활건강 | Liquid Crystal Gel Whitening Cosmetic Composition_ |
| JP2009298748A (en) * | 2008-06-17 | 2009-12-24 | Septem Soken:Kk | Liquid crystal lamellar type composition for cosmetic and cosmetic containing the same |
| JP2012508769A (en) * | 2008-11-14 | 2012-04-12 | アーチャー・ダニエルズ・ミッドランド カンパニー | Organogel composition and production method |
| CN106176363A (en) * | 2016-07-26 | 2016-12-07 | 西安艾尔菲生物科技有限公司 | A kind of cosmetics with careful pore effect and preparation method thereof |
| JP2017031111A (en) * | 2015-08-04 | 2017-02-09 | キッコーマンバイオケミファ株式会社 | Skin quality improvement composition, and cosmetics |
| JP2019043930A (en) * | 2017-08-31 | 2019-03-22 | クラシエホームプロダクツ株式会社 | Method for producing skin cosmetic |
| JP2020105146A (en) * | 2018-12-28 | 2020-07-09 | ちふれホールディングス株式会社 | Liquid crystal forming composition, liquid crystal-containing emulsifier, and liquid crystal-containing cosmetics in cream or film form |
| JP2020109074A (en) * | 2019-12-03 | 2020-07-16 | ちふれホールディングス株式会社 | Composition for forming liquid crystal, liquid crystal-containing emulsifier, and liquid crystal-containing cosmetic that is creamy or film-like |
-
1991
- 1991-08-02 JP JP3194316A patent/JPH0539485A/en active Pending
Cited By (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5726163A (en) * | 1994-01-19 | 1998-03-10 | Taisho Pharmaceutical Co., Ltd. | Dermatologic composition |
| WO1995019762A1 (en) * | 1994-01-19 | 1995-07-27 | Taisho Pharmaceutical Co., Ltd. | Dermatologic composition |
| FR2730409A1 (en) * | 1995-02-15 | 1996-08-14 | Dior Christian Parfums | USE OF GALACTOLIPIDS, IN PARTICULAR GALACTOSYLGLYCERIDES, AND EXTRACTS OF NATURAL ORIGIN CONTAINING THESE PRODUCTS, IN THE COSMETIC, PHARMACEUTICAL AND IN PARTICULAR DERMATOLOGICAL FIELDS |
| WO1996025142A1 (en) * | 1995-02-15 | 1996-08-22 | Parfums Christian Dior | Use of galactosylglycerides and of naturally occurring extracts containing such products in cosmetics, pharmaceutics and particularly dermatology |
| EP0875232A1 (en) * | 1997-05-02 | 1998-11-04 | Takasago International Corporation | A lipid composition containing liquid crystal phase |
| US6348201B2 (en) | 1997-05-30 | 2002-02-19 | Kibun Food Chemifa Co., Ltd. | External composition for skin comprising sphingoglycolipid |
| US6514744B2 (en) | 1997-05-30 | 2003-02-04 | Kibun Food Chemifa Co., Ltd. | External compositions for skin comprising sphingoglycolipid |
| US6669932B2 (en) | 1997-06-10 | 2003-12-30 | Sunstar Inc. | Skin-whitening cosmetic |
| WO1998056338A1 (en) * | 1997-06-10 | 1998-12-17 | Sunstar Inc. | Skin-lightening cosmetic |
| US6306915B1 (en) | 1998-08-07 | 2001-10-23 | Kibun Food Chemifa Co., Ltd | Methods of making an emulsified composition |
| KR100567373B1 (en) * | 1998-12-17 | 2007-03-15 | 주식회사 엘지생활건강 | Liquid Crystal Gel Whitening Cosmetic Composition_ |
| EP1043016A1 (en) * | 1999-03-30 | 2000-10-11 | Sodic Sa | A plant extract based on glycerides, a method for the preparation of this extract and a cosmetic composition containing the same |
| US6723704B2 (en) | 2000-06-29 | 2004-04-20 | Kibun Food Chemifa Co., Ltd. | Sphingoglycolipid |
| KR100439595B1 (en) * | 2001-05-18 | 2004-07-12 | 주식회사 엘지생활건강 | Tocopherol-containing Ceramide Liquid Crystal Capsule, Emulsion thereof and Cosmetic comprising the same |
| KR100434898B1 (en) * | 2001-06-26 | 2004-06-07 | 나드리화장품주식회사 | Cosmetic composition containing medical plant complex extracts stabilized with liquid crystalsome |
| JP2009298748A (en) * | 2008-06-17 | 2009-12-24 | Septem Soken:Kk | Liquid crystal lamellar type composition for cosmetic and cosmetic containing the same |
| JP2012508769A (en) * | 2008-11-14 | 2012-04-12 | アーチャー・ダニエルズ・ミッドランド カンパニー | Organogel composition and production method |
| JP2017031111A (en) * | 2015-08-04 | 2017-02-09 | キッコーマンバイオケミファ株式会社 | Skin quality improvement composition, and cosmetics |
| CN106176363A (en) * | 2016-07-26 | 2016-12-07 | 西安艾尔菲生物科技有限公司 | A kind of cosmetics with careful pore effect and preparation method thereof |
| CN106176363B (en) * | 2016-07-26 | 2019-04-02 | 西安艾尔菲生物科技有限公司 | A kind of cosmetics and preparation method thereof with careful pore effect |
| JP2019043930A (en) * | 2017-08-31 | 2019-03-22 | クラシエホームプロダクツ株式会社 | Method for producing skin cosmetic |
| JP2020105146A (en) * | 2018-12-28 | 2020-07-09 | ちふれホールディングス株式会社 | Liquid crystal forming composition, liquid crystal-containing emulsifier, and liquid crystal-containing cosmetics in cream or film form |
| JP2020109074A (en) * | 2019-12-03 | 2020-07-16 | ちふれホールディングス株式会社 | Composition for forming liquid crystal, liquid crystal-containing emulsifier, and liquid crystal-containing cosmetic that is creamy or film-like |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH0539485A (en) | Liquid crystal composition and cosmetic containing the same | |
| TW381028B (en) | Skin blanching material for cosmetics use | |
| DE3713493C3 (en) | Cosmetic or pharmaceutical composition based on an aqueous dispersion of lipid globules | |
| JP2554880B2 (en) | Skin cosmetics | |
| JP6139206B2 (en) | Translucent or transparent composition | |
| WO2004004676A1 (en) | Vesicle dispersion and cosmetic containing the same | |
| KR20100121995A (en) | Manufacturing method of composition of 2-layer | |
| JP2007153801A (en) | Humectant and cosmetic containing the same | |
| JP2005179313A (en) | Method for producing base agent for skin cosmetic, and skin cosmetic | |
| WO1998013436A1 (en) | Humectant composition, base containing the same, and cosmetic material or external preparation containing said humectant composition | |
| JPH0776513A (en) | Cosmetic for preventing skin aging | |
| JP6606833B2 (en) | Ceramides-containing liposome dispersion | |
| JP3000224B2 (en) | Skin cosmetics | |
| JP2001010946A (en) | Skin cosmetic | |
| JP6185477B2 (en) | Vesicle composition, external preparation for skin and cosmetic containing the same | |
| JP2929318B2 (en) | Liquid crystal composition and cosmetic containing the same | |
| CN111432778A (en) | Cochleates utilizing phosphatidylserine/anionic surfactant/calcium chloride | |
| JP3783385B2 (en) | Method for producing liposome dispersion and cosmetic using the same | |
| JPH1160462A (en) | Skin cosmetic | |
| JP2949451B2 (en) | Liquid crystal composition and cosmetic containing the same | |
| KR101178595B1 (en) | Two-layered cosmetics | |
| JPH0539484A (en) | Liquid crystal composition and cosmetic containing the same | |
| JP2018065762A (en) | Ursolic acid-containing liposome dispersion liquid | |
| JP2001072570A (en) | Skin preparation for external use | |
| KR20080011535A (en) | Cosmetic composition for protecting lip comprising ceramide and synthetic palmitoylpentapeptide as an active ingredient |